DRDGOLD CFO sells 8,313 shares after award vests

DRDGOLD’s CFO exercised incentive Deferred Shares into Ordinary Shares and sold a portion in a pooled market sale, retaining most of the vested shares.

Rhea-AI Filing Summary

DRDGOLD LTD (DRD) Chief Financial Officer Henriette Hooijer reported transactions in company equity awards and shares. On August 13, 2026, 18,472 Deferred Shares granted under the Single Incentive Plan vested and were settled on a one-for-one basis into Ordinary Shares for no consideration, and Hooijer acquired 18,472 Ordinary Shares. A pooled sale then disposed of 8,313 of those Ordinary Shares on August 31 and September 1, 2026 at an average price of $2.7545 per share (converted from South African rand), with the remaining 10,159 Ordinary Shares retained in her name. Following these events, she held 110,965 Deferred Shares, and no Rule 10b5-1 trading plan is reported.

Insider Trade Summary

Exercise and sale activity reported; no spread calculated

Exercise and Sale 3 txns

Insider Hooijer Henriette

Role Chief Financial Officer

Sold 8,313 shs ($23K)

Approx. gross sale proceeds $23K

Approx. exercise cost $0.00

Type	Security	Shares	Price	Value
Sale	Ordinary Shares F2, F3	8,313	$2.7545	$23K
Exercise	Deferred Shares F1, F4	18,472	$0.00	$0.00
Exercise	Ordinary Shares F1	18,472	$0.00	$0.00

Holdings After Transaction: Deferred Shares — 110,965 contracts (Direct); Ordinary Shares — 172,099 shares (Direct)

Footnotes (4)

1. F1. On August 13, 2026, 18,472 deferred shares of DRDGOLD Limited (the "Company") previously awarded to the Reporting Person under the Company's Single Incentive Plan (the "Deferred Shares") vested and were settled on a one-for-one basis in Ordinary Shares for no consideration.
2. F2. Represents 8,313 Ordinary Shares sold on behalf of the Reporting Person as part of a pooled sale conducted on August 31 and September 1, 2026, following the vesting and settlement of 18,472 Deferred Shares described in footnote 1. The remaining 10,159 Ordinary Shares were transferred to and retained in the Reporting Person's own name.
3. F3. The underlying transaction was denominated in South African rand ("ZAR"). For the purposes of this table, the price reported in United States dollars has been converted from ZAR using the South African Reserve Bank exchange rate in effect on the transaction date. The average sale price was ZAR 44.4764 per Ordinary Share.
4. F4. The amount reported in Table II, Column 9 reflects the subsequent acquisition of Deferred Shares previously reported on the Reporting Person's Form 4 filed on August 27, 2026 and represents the Reporting Person's current holdings of Deferred Shares.

Key Figures

Ordinary Shares sold: 8,313 shares Average sale price: $2.7545 per share Deferred Shares vested and settled: 18,472 shares +3 more

6 metrics

Ordinary Shares sold 8,313 shares Pooled sale on August 31 and September 1, 2026

Average sale price $2.7545 per share Ordinary Shares sale, price converted from ZAR

Deferred Shares vested and settled 18,472 shares Converted into Ordinary Shares on August 13, 2026

Ordinary Shares retained from vesting 10,159 shares Portion of 18,472 vested Ordinary Shares retained

Deferred Shares held after transaction 110,965 shares Reported current holdings of Deferred Shares

Average sale price in ZAR ZAR 44.4764 per share Local-currency average price for Ordinary Shares sold

Key Terms

Deferred Shares, Single Incentive Plan, pooled sale, South African Reserve Bank exchange rate

4 terms

Deferred Shares financial

"18,472 deferred shares of DRDGOLD Limited previously awarded to the Reporting Person"

Deferred shares are a class of stock whose economic benefits or certain shareholder rights are delayed or paid later than ordinary shares—for example, dividends may be paid only after other shareholders receive theirs, or voting or redemption rights may be postponed. For investors, that timing difference matters because deferred shares typically offer lower near-term income and different risk, affecting expected returns, priority in payouts, and the share’s market value; think of them like a delayed paycheck compared with a regular salary.

Single Incentive Plan financial

"previously awarded to the Reporting Person under the Company's Single Incentive Plan"

pooled sale financial

"Ordinary Shares sold on behalf of the Reporting Person as part of a pooled sale"

South African Reserve Bank exchange rate financial

"converted from ZAR using the South African Reserve Bank exchange rate in effect"

FAQ

What insider transactions did DRD CFO Henriette Hooijer report on this Form 4?

She reported the vesting and settlement of 18,472 Deferred Shares into Ordinary Shares on August 13, 2026, and a subsequent pooled sale of 8,313 Ordinary Shares on August 31 and September 1, 2026, retaining 10,159 Ordinary Shares from that vesting.

How many DRD Deferred Shares did the CFO exercise or convert into Ordinary Shares?

On August 13, 2026, the CFO had 18,472 Deferred Shares vest and settle into 18,472 Ordinary Shares on a one-for-one basis for no consideration under DRDGOLD’s Single Incentive Plan.

What price did the DRD CFO receive for the Ordinary Shares sold?

The pooled sale of 8,313 Ordinary Shares executed on August 31 and September 1, 2026 achieved an average price of $2.7545 per share, reported in U.S. dollars after conversion from South African rand based on the South African Reserve Bank exchange rate.

How many DRD Ordinary Shares from the vested award did the CFO retain?

From the 18,472 Ordinary Shares received upon vesting, the CFO had 8,313 sold in a pooled sale, while the remaining 10,159 Ordinary Shares were transferred to and retained in her own name.

What are the DRD CFO’s remaining Deferred Share holdings after these transactions?

After the August 13, 2026 vesting and related activity, the CFO’s reported holdings of Deferred Shares are 110,965 Deferred Shares, as reflected in Table II, Column 9 for the derivative securities.

Were the DRD CFO’s reported share sales made under a Rule 10b5-1 trading plan?

No. The filing’s Rule 10b5-1 checkbox is not marked as an affirmative plan, and the footnotes describing the 8,313 Ordinary Shares pooled sale do not state that the transactions were made pursuant to a Rule 10b5-1 trading plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/03/2026 - 05:50 PM Accepted by SEC EDGAR 09/03/2026 - 04:39 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Hooijer Henriette

(Last) (First) (Middle)

CYCAD HOUSE, BUILDING 17, GROUND FLOOR

CNR 14TH AVENUE AND HENDRIK POTGIETER RD

(Street)

WELTEVREDEN PARK 1709

(City) (State) (Zip)

SOUTH AFRICA

(Country)

2. Issuer Name and Ticker or Trading Symbol
DRDGOLD LTD [ DRD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/13/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	08/13/2026		M		18,472(1)	A	$0	180,412	D
Ordinary Shares	09/01/2026		S		8,313(2)	D	$2.7545(3)	172,099	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Deferred Shares	$0	08/13/2026		M			18,472(1)	(1)	(1)	Ordinary Shares	18,472	$0	110,965(4)	D

Explanation of Responses:

1. On August 13, 2026, 18,472 deferred shares of DRDGOLD Limited (the "Company") previously awarded to the Reporting Person under the Company's Single Incentive Plan (the "Deferred Shares") vested and were settled on a one-for-one basis in Ordinary Shares for no consideration.

2. Represents 8,313 Ordinary Shares sold on behalf of the Reporting Person as part of a pooled sale conducted on August 31 and September 1, 2026, following the vesting and settlement of 18,472 Deferred Shares described in footnote 1. The remaining 10,159 Ordinary Shares were transferred to and retained in the Reporting Person's own name.

3. The underlying transaction was denominated in South African rand ("ZAR"). For the purposes of this table, the price reported in United States dollars has been converted from ZAR using the South African Reserve Bank exchange rate in effect on the transaction date. The average sale price was ZAR 44.4764 per Ordinary Share.

4. The amount reported in Table II, Column 9 reflects the subsequent acquisition of Deferred Shares previously reported on the Reporting Person's Form 4 filed on August 27, 2026 and represents the Reporting Person's current holdings of Deferred Shares.

Remarks:

	/s/ Henriette Hooijer	09/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)